TreeWAS – Variant ID: rs13401104

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.135	0.865	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.134	0.866	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.134	0.866	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.130	0.870	0.000
C90.0 Multiple myeloma	0.127	0.873	0.000
C84.5 Other and unspecified T-cell lymphomas	0.126	0.874	0.000
C83.0 Small cell (diffuse)	0.125	0.875	0.000
C92 Myeloid leukaemia	0.119	0.881	0.000
C84.4 Peripheral T-cell lymphoma	0.117	0.883	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.115	0.885	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.113	0.887	0.000
C83.3 Large cell (diffuse)	0.113	0.887	0.000
C91 Lymphoid leukaemia	0.107	0.893	0.000
C83.7 Burkitt's tumour	0.104	0.896	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.103	0.896	0.000
C84.0 Mycosis fungoides	0.103	0.897	0.000
C92.4 Acute promyelocytic leukaemia	0.101	0.899	0.000
C83.1 Small cleaved cell (diffuse)	0.100	0.900	0.000
C88 Malignant immunoproliferative diseases	0.099	0.901	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.097	0.903	0.000
C94 Other leukaemias of specified cell type	0.097	0.903	0.000
C86 Other specified types of T/NK-cell lymphoma	0.097	0.903	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.097	0.903	0.000
C83.6 Undifferentiated (diffuse)	0.096	0.904	0.000
C83.5 Lymphoblastic (diffuse)	0.096	0.904	0.000
C83.4 Immunoblastic (diffuse)	0.096	0.904	0.000
C83.2 Mixed small and large cell (diffuse)	0.096	0.904	0.000
C95 Leukaemia of unspecified cell type	0.096	0.904	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.096	0.904	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.096	0.904	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.096	0.904	0.000
C84.3 Lymphoepithelioid lymphoma	0.096	0.904	0.000
C84.2 T-zone lymphoma	0.096	0.904	0.000
C84.1 Sezary's diease	0.096	0.904	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.094	0.906	0.000
C93 Monocytic leukaemia	0.094	0.906	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.093	0.907	0.000
C90.1 Plasma cell leukaemia	0.093	0.907	0.000
C91.1 Chronic lymphocytic leukaemia	0.092	0.908	0.000
C90.3 Solitary plasmacytoma	0.092	0.908	0.000
C92.0 Acute myeloid leukaemia	0.091	0.909	0.000
C92.1 Chronic myeloid leukaemia	0.091	0.909	0.000
C90.2 Plasmacytoma, extramedullary	0.091	0.909	0.000
C92.7 Other myeloid leukaemia	0.086	0.913	0.000
C92.9 Myeloid leukaemia, unspecified	0.085	0.914	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.085	0.914	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.085	0.914	0.000
C92.5 Acute myelomonocytic leukaemia	0.085	0.914	0.000
C92.3 Myeloid sarcoma	0.085	0.914	0.000
C92.2 Subacute myeloid leukaemia	0.085	0.914	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.082	0.918	0.000
C85.0 Lymphosarcoma	0.082	0.918	0.000
C91.0 Acute lymphoblastic leukaemia	0.080	0.920	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.077	0.923	0.000
C91.7 Other lymphoid leukaemia	0.077	0.923	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.077	0.923	0.000
C91.5 Adult T-cell leukaemia	0.077	0.923	0.000
C91.3 Prolymphocytic leukaemia	0.077	0.923	0.000
C91.2 Subacute lymphocytic leukaemia	0.077	0.923	0.000
C85.1 B-cell lymphoma, unspecified	0.074	0.926	0.000
C91.9 Lymphoid leukaemia, unspecified	0.074	0.926	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.073	0.927	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.071	0.928	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.071	0.929	0.000
C88.7 Other malignant immunoproliferative diseases	0.071	0.929	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.071	0.929	0.000
C88.3 Immunoproliferative small intestinal disease	0.071	0.929	0.000
C88.2 Gamma heavy chain disease	0.071	0.929	0.000
C88.1 Alpha heavy chain disease	0.071	0.929	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.070	0.930	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.070	0.930	0.000
C86.4 Blastic NK-cell lymphoma	0.070	0.930	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.070	0.930	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.070	0.930	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.070	0.930	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.070	0.930	0.000
C94.7 Other specified leukaemias	0.070	0.930	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.070	0.930	0.000
C94.5 Acute myelofibrosis	0.070	0.930	0.000
C94.4 Acute panmyelosis	0.070	0.930	0.000
C94.3 Mast cell leukaemia	0.070	0.930	0.000
C94.2 Acute megakaryoblastic leukaemia	0.070	0.930	0.000
C94.1 Chronic erythraemia	0.070	0.930	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.070	0.930	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.070	0.930	0.000
C96.8 Histiocytic sarcoma	0.070	0.930	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.070	0.930	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.070	0.930	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.070	0.930	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.070	0.930	0.000
C96.3 True histiocytic lymphoma	0.070	0.930	0.000
C96.2 Malignant mast cell tumour	0.070	0.930	0.000
C96.1 Malignant histiocytosis	0.070	0.930	0.000
C96.0 Letterer-Siwe disease	0.070	0.930	0.000
C95.7 Other leukaemia of unspecified cell type	0.069	0.931	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.069	0.931	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.069	0.931	0.000
C95.0 Acute leukaemia of unspecified cell type	0.069	0.931	0.000
C95.9 Leukaemia, unspecified	0.068	0.932	0.000
C93.9 Monocytic leukaemia, unspecified	0.067	0.932	0.000
C93.7 Other monocytic leukaemia	0.067	0.932	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.067	0.932	0.000
C93.2 Subacute monocytic leukaemia	0.067	0.932	0.000
C93.0 Acute monocytic leukaemia	0.067	0.932	0.000
C93.1 Chronic monocytic leukaemia	0.064	0.936	0.000
C91.4 Hairy-cell leukaemia	0.063	0.936	0.000
C81 Hodgkin's disease	0.059	0.940	0.001
C82.2 Large cell, follicular	0.059	0.941	0.000
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.057	0.943	0.000
C82.3 Follicular lymphoma grade IIIa	0.056	0.943	0.000
C82.6 Cutaneous follicle centre lymphoma	0.051	0.948	0.000
C82.5 Diffuse follicle centre lymphoma	0.051	0.948	0.000
C82.4 Follicular lymphoma grade IIIb	0.051	0.948	0.000
C82.0 Small cleaved cell, follicular	0.050	0.950	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.047	0.953	0.000
C81.2 Mixed cellularity	0.046	0.954	0.001
C82.1 Mixed small cleaved and large cell, follicular	0.043	0.957	0.000
C81.7 Other Hodgkin's disease	0.043	0.957	0.001
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.043	0.957	0.001
C81.3 Lymphocytic depletion	0.043	0.957	0.001
C81.0 Lymphocytic predominance	0.043	0.957	0.001
D24 Benign neoplasm of breast	0.040	0.960	0.000
C81.1 Nodular sclerosis	0.035	0.964	0.001
M72.0 Palmar fascial fibromatosis [Dupuytren]	0.031	0.969	0.000
M72.09 Palmar fascial fibromatosis [Dupuytren]-Site unspec	0.022	0.978	0.000
M72.08 Palmar fascial fibromatosis [Dupuytren]-Other	0.022	0.978	0.000
M72.07 Palmar fascial fibromatosis [Dupuytren]-Ankle/Foot	0.022	0.978	0.000
M72.06 Palmar fascial fibromatosis [Dupuytren]-Lower Leg	0.022	0.978	0.000
M72.05 Palmar fascial fibromatosis [Dupuytren]-Pelvic/Thigh	0.022	0.978	0.000
M72.03 Palmar fascial fibromatosis [Dupuytren]-Forearm	0.022	0.978	0.000
M72.02 Palmar fascial fibromatosis [Dupuytren]-Upper arm	0.022	0.978	0.000
M72.01 Palmar fascial fibromatosis [Dupuytren]-Shldr region	0.022	0.978	0.000
M72.00 Palmar fascial fibromatosis [Dupuytren]-Mult sites	0.022	0.978	0.000
N60.1 Diffuse cystic mastopathy	0.022	0.978	0.000
N60 Benign mammary dysplasia	0.021	0.979	0.000
N60.3 Fibrosclerosis of breast	0.021	0.979	0.000
N60.9 Benign mammary dysplasia, unspecified	0.018	0.981	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.018	0.982	0.000
N60.2 Fibroadenosis of breast	0.018	0.982	0.000
N60.0 Solitary cyst of breast	0.017	0.983	0.000
C81.9 Hodgkin's disease, unspecified	0.013	0.985	0.002
S83.2 Tear of meniscus, current	0.014	0.986	0.000
N60.4 Mammary duct ectasia	0.013	0.987	0.000
N60.8 Other benign mammary dysplasias	0.013	0.987	0.000
S80.9 Superficial injury of lower leg, unspecified	0.013	0.987	0.000
M72 Fibroblastic disorders	0.011	0.989	0.000
S80 Superficial injury of lower leg	0.011	0.989	0.000
S80.8 Other superficial injuries of lower leg	0.010	0.990	0.000
S80.1 Contusion of other and unspecified parts of lower leg	0.009	0.991	0.000
N05.9 Unspecified	0.000	0.991	0.009
S83 Dislocation, sprain and strain of joints and ligaments of knee	0.009	0.991	0.000
S80.7 Multiple superficial injuries of lower leg	0.009	0.991	0.000
M72.9 Fibroblastic disorder, unspecified	0.008	0.992	0.000
M72.8 Other fibroblastic disorders	0.008	0.992	0.000
M72.6 Necrotizing fasciitis	0.008	0.992	0.000
M72.5 Fasciitis, not elsewhere classified	0.008	0.992	0.000
M72.4 Pseudosarcomatous fibromatosis	0.008	0.992	0.000
M72.3 Nodular fasciitis	0.008	0.992	0.000
M72.1 Knuckle pads	0.008	0.992	0.000
M93.9 Osteochondropathy, unspecified	0.000	0.992	0.008
I95.1 Orthostatic hypotension	0.000	0.992	0.008
M72.2 Plantar fascial fibromatosis	0.007	0.992	0.000
S80-S89 Injuries to the knee and lower leg	0.007	0.993	0.000
O42.0 Premature rupture of membranes, onset of labour within 24 hours	0.007	0.993	0.000
S83.4 Sprain and strain involving (fibular)(tibial) collateral ligamnent of knee	0.007	0.993	0.000
S83.7 Injury to multiple structures of knee	0.007	0.993	0.000
S83.3 Tear of articular cartilage of knee, current	0.007	0.993	0.000
S83.1 Dislocation of knee	0.007	0.993	0.000
S83.0 Dislocation of patella	0.007	0.993	0.000
M93 Other osteochondropathies	0.000	0.993	0.007
A41.5 Septicaemia due to other Gram-negative organisms	0.007	0.993	0.000
Z90.7 Acquired absence of genital organ(s)	0.007	0.993	0.000
N05 Unspecified nephritic syndrome	0.000	0.993	0.007
M72.19 Knuckle pads (Site unspecified)	0.006	0.994	0.000
M72.18 Knuckle pads-Other	0.006	0.994	0.000
M72.17 Knuckle pads (Ankle and foot)	0.006	0.994	0.000
M72.16 Knuckle pads-Lower Leg	0.006	0.994	0.000
M72.15 Knuckle pads-Pelvic/Thigh	0.006	0.994	0.000
M72.14 Knuckle pads (Hand)	0.006	0.994	0.000
M72.13 Knuckle pads-Forearm	0.006	0.994	0.000
M72.12 Knuckle pads-Upper arm	0.006	0.994	0.000
M72.11 Knuckle pads-Shldr region	0.006	0.994	0.000
M72.10 Knuckle pads (Multiple sites)	0.006	0.994	0.000
M72.39 Nodular fasciitis-Site unspec	0.006	0.994	0.000
M72.38 Nodular fasciitis-Other	0.006	0.994	0.000
M72.37 Nodular fasciitis-Ankle/Foot	0.006	0.994	0.000
M72.36 Nodular fasciitis-Lower Leg	0.006	0.994	0.000
M72.35 Nodular fasciitis-Pelvic/Thigh	0.006	0.994	0.000
M72.34 Nodular fasciitis-Hand	0.006	0.994	0.000
M72.33 Nodular fasciitis-Forearm	0.006	0.994	0.000
M72.32 Nodular fasciitis-Upper arm	0.006	0.994	0.000
M72.31 Nodular fasciitis-Shldr region	0.006	0.994	0.000
M72.30 Nodular fasciitis-Mult sites	0.006	0.994	0.000
M72.49 Pseudosarcomatous fibromatosis (Site unspecified)	0.006	0.994	0.000
M72.48 Pseudosarcomatous fibromatosis (Other)	0.006	0.994	0.000
M72.47 Pseudosarcomatous fibromatosis (Ankle and foot)	0.006	0.994	0.000
M72.46 Pseudosarcomatous fibromatosis (Lower leg)	0.006	0.994	0.000
M72.45 Pseudosarcomatous fibromatosis (Pelvic region and thigh)	0.006	0.994	0.000
M72.44 Pseudosarcomatous fibromatosis (Hand)	0.006	0.994	0.000
M72.43 Pseudosarcomatous fibromatosis (Forearm)	0.006	0.994	0.000
M72.42 Pseudosarcomatous fibromatosis (Upper arm)	0.006	0.994	0.000
M72.41 Pseudosarcomatous fibromatosis (Shoulder region)	0.006	0.994	0.000
M72.40 Pseudosarcomatous fibromatosis (Multiple sites)	0.006	0.994	0.000
M72.59 Fasciitis, not elsewhere classified-Site unspec	0.006	0.994	0.000
M72.58 Fasciitis, not elsewhere classified-Other	0.006	0.994	0.000
M72.57 Fasciitis, not elsewhere classified-Ankle/Foot	0.006	0.994	0.000
M72.56 Fasciitis, not elsewhere classified-Lower Leg	0.006	0.994	0.000
M72.55 Fasciitis, not elsewhere classified-Pelvic/Thigh	0.006	0.994	0.000
M72.54 Fasciitis, not elsewhere classified-Hand	0.006	0.994	0.000
M72.53 Fasciitis, not elsewhere classified-Forearm	0.006	0.994	0.000
M72.52 Fasciitis, not elsewhere classified-Upper arm	0.006	0.994	0.000
M72.51 Fasciitis, not elsewhere classified-Shldr region	0.006	0.994	0.000
M72.50 Fasciitis, not elsewhere classified-Mult sites	0.006	0.994	0.000
M72.69 Necrotizing fasciitis (Site unspecified)	0.006	0.994	0.000
M72.68 Necrotizing fasciitis (Other)	0.006	0.994	0.000
M72.67 Necrotizing fasciitis (Ankle and foot)	0.006	0.994	0.000
M72.66 Necrotizing fasciitis (Lower leg)	0.006	0.994	0.000
M72.65 Necrotizing fasciitis (Pelvic region and thigh)	0.006	0.994	0.000
M72.64 Necrotizing fasciitis (Hand)	0.006	0.994	0.000
M72.63 Necrotizing fasciitis (Forearm)	0.006	0.994	0.000
M72.62 Necrotizing fasciitis (Upper arm)	0.006	0.994	0.000
M72.61 Necrotizing fasciitis (Shoulder region)	0.006	0.994	0.000
M72.60 Necrotizing fasciitis (Multiple sites)	0.006	0.994	0.000
M72.89 Other fibroblastic disorders (Site unspecified)	0.006	0.994	0.000
M72.88 Other fibroblastic disorders (Other)	0.006	0.994	0.000
M72.87 Other fibroblastic disorders (Ankle and foot)	0.006	0.994	0.000
M72.86 Other fibroblastic disorders (Lower leg)	0.006	0.994	0.000
M72.85 Other fibroblastic disorders (Pelvic region and thigh)	0.006	0.994	0.000
M72.84 Other fibroblastic disorders (Hand)	0.006	0.994	0.000
M72.83 Other fibroblastic disorders (Forearm)	0.006	0.994	0.000
M72.82 Other fibroblastic disorders (Upper arm)	0.006	0.994	0.000
M72.81 Other fibroblastic disorders (Shoulder region)	0.006	0.994	0.000
M72.80 Other fibroblastic disorders (Multiple sites)	0.006	0.994	0.000
M72.99 Fibroblastic disorder, unspecified (Site unspecified)	0.006	0.994	0.000
M72.98 Fibroblastic disorder, unspecified (Other)	0.006	0.994	0.000
M72.97 Fibroblastic disorder, unspecified (Ankle and foot)	0.006	0.994	0.000
M72.96 Fibroblastic disorder, unspecified (Lower leg)	0.006	0.994	0.000
M72.95 Fibroblastic disorder, unspecified (Pelvic region and thigh)	0.006	0.994	0.000
M72.94 Fibroblastic disorder, unspecified (Hand)	0.006	0.994	0.000
M72.93 Fibroblastic disorder, unspecified (Forearm)	0.006	0.994	0.000
M72.92 Fibroblastic disorder, unspecified (Upper arm)	0.006	0.994	0.000
M72.91 Fibroblastic disorder, unspecified (Shoulder region)	0.006	0.994	0.000
M72.90 Fibroblastic disorder, unspecified (Multiple sites)	0.006	0.994	0.000
M75.0 Adhesive capsulitis of shoulder	0.000	0.994	0.006
S86 Injury of muscle and tendon at lower leg level	0.006	0.994	0.000
N05.1 Focal and segmental glomerular lesions	0.000	0.994	0.006
T46 Poisoning by agents primarily affecting the cardiovascular system	0.006	0.994	0.000
M72.29 Plantar fascial fibromatosis-Site unspec	0.005	0.994	0.000
M72.28 Plantar fascial fibromatosis-Other	0.005	0.994	0.000
M72.26 Plantar fascial fibromatosis-Lower Leg	0.005	0.994	0.000
M72.25 Plantar fascial fibromatosis-Pelvic/Thigh	0.005	0.994	0.000
M72.24 Plantar fascial fibromatosis-Hand	0.005	0.994	0.000
M72.23 Plantar fascial fibromatosis-Forearm	0.005	0.994	0.000
M72.22 Plantar fascial fibromatosis-Upper arm	0.005	0.994	0.000
M72.21 Plantar fascial fibromatosis-Shldr region	0.005	0.994	0.000
M72.20 Plantar fascial fibromatosis-Mult sites	0.005	0.994	0.000
N05.2 Diffuse membranous glomerulonephritis	0.000	0.994	0.006
D63.0 Anaemia in neoplastic disease	0.006	0.994	0.000
N05.8 Other	0.000	0.994	0.006
S88 Traumatic amputation of lower leg	0.005	0.994	0.000
S87 Crushing injury of lower leg	0.005	0.994	0.000
S85 Injury of blood vessels at lower leg level	0.005	0.994	0.000
S84 Injury of nerves at lower leg level	0.005	0.994	0.000
S81.8 Open wound of other parts of lower leg	0.005	0.995	0.000
M91-M94 Chondropathies	0.000	0.995	0.005
S81 Open wound of lower leg	0.005	0.995	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.005	0.995	0.000
T46.1 Calcium-channel blockers	0.005	0.995	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.005	0.995	0.000
L40.9 Psoriasis, unspecified	0.005	0.995	0.000
M94 Other disorders of cartilage	0.000	0.995	0.005
S83.5 Sprain and strain involving (anterior)(posterior) cruciate ligament of knee	0.005	0.995	0.000
M92 Other juvenile osteochondrosis	0.000	0.995	0.005
M93.8 Other specified osteochondropathies	0.000	0.995	0.005
M93.2 Osteochondritis dissecans	0.000	0.995	0.005
M93.1 Kienbock's disease of adults	0.000	0.995	0.005
M93.0 Slipped upper femoral epiphysis (nontraumatic)	0.000	0.995	0.005
S86.2 Injury of muscle(s) and tendon(s) of anterior muscle group at lower leg level	0.005	0.995	0.000
N05.6 Dense deposit disease	0.000	0.995	0.005
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.995	0.005
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.995	0.005
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.995	0.005
N05.0 Minor glomerular abnormality	0.000	0.995	0.005
S80.0 Contusion of knee	0.005	0.995	0.000
S86.8 Injury of other muscles and tendons at lower leg level	0.005	0.995	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.005	0.995	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.005	0.995	0.000
M72.27 Plantar fascial fibromatosis-Ankle/Foot	0.005	0.995	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.005	0.995	0.000
M94.8 Other specified disorders of cartilage	0.000	0.995	0.005
N05.7 Diffuse crescentic glomerulonephritis	0.000	0.995	0.005
R40.2 Coma, unspecified	0.000	0.995	0.005
S89 Other and unspecified injuries of lower leg	0.005	0.995	0.000
M92.7 Juvenile osteochondrosis of metatarsus	0.000	0.995	0.004
M92.6 Juvenile osteochondrosis of tarsus	0.000	0.995	0.004
S86.0 Injury of Achilles tendon	0.004	0.995	0.000
S86.7 Injury of multiple muscles and tendons at lower leg level	0.004	0.995	0.000
S86.3 Injury of muscle(s) and tendon(s) of peroneal muscle group at lower leg level	0.004	0.995	0.000
S83.6 Sprain and strain of other and unspecified parts of knee	0.004	0.996	0.000
M91 Juvenile osteochondrosis of hip and pelvis	0.000	0.996	0.004
M94.9 Disorder of cartilage, unspecified	0.000	0.996	0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
T46.7 Peripheral vasodilators	0.004	0.996	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
S81.7 Multiple open wounds of lower leg	0.004	0.996	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.004	0.996	0.000
M94.88 Other specified disorders of cartilage (Other)	0.000	0.996	0.004
S84.9 Injury of unspecified nerve at lower leg level	0.004	0.996	0.000
S84.8 Injury of other nerves at lower leg level	0.004	0.996	0.000
S84.7 Injury of multiple nerves at lower leg level	0.004	0.996	0.000
S84.2 Injury of cutaneous sensory nerve at lower leg level	0.004	0.996	0.000
S84.1 Injury of peroneal nerve at lower leg level	0.004	0.996	0.000
S84.0 Injury of tibial nerve at lower leg level	0.004	0.996	0.000
S85.9 Injury of unspecified blood vessel at lower leg level	0.004	0.996	0.000
S85.8 Injury of other blood vessels at lower leg level	0.004	0.996	0.000
S85.7 Injury of multiple blood vessels at lower leg level	0.004	0.996	0.000
S85.5 Injury of popliteal vein	0.004	0.996	0.000
S85.4 Injury of lesser saphenous vein at lower leg level	0.004	0.996	0.000
S85.3 Injury of greater saphenous vein at lower leg level	0.004	0.996	0.000
S85.2 Injury of peroneal artery	0.004	0.996	0.000
S85.1 Injury of (anterior)(posterior) tibial artery	0.004	0.996	0.000
S85.0 Injury of popliteal artery	0.004	0.996	0.000
S87.8 Crushing injury of other and unspecified parts of lower leg	0.004	0.996	0.000
S87.0 Crushing injury of knee	0.004	0.996	0.000
S88.9 Traumatic amputation of lower leg, level unspecified	0.004	0.996	0.000
S88.1 Traumatic amputation at level between knee and ankle	0.004	0.996	0.000
S88.0 Traumatic amputation at knee level	0.004	0.996	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
T45.5 Anticoagulants	0.004	0.996	0.000
S86.1 Injury of other muscle(s) and tendon(s) of posterior muscle group at lower leg level	0.004	0.996	0.000
T45.2 Vitamins, not elsewhere classified	0.004	0.996	0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.000	0.996	0.004
M94.2 Chondromalacia	0.000	0.996	0.004
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.996	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
O46.9 Antepartum haemorrhage, unspecified	0.000	0.996	0.004
S86.9 Injury of unspecified muscle and tendon at lower leg level	0.004	0.996	0.000
M94.3 Chondrolysis	0.000	0.996	0.004
M94.1 Relapsing polychondritis	0.000	0.996	0.004
M94.0 Chondrocostal junction syndrome [Tietze]	0.000	0.996	0.004
M92.5 Juvenile osteochondrosis of tibia and fibula	0.000	0.996	0.004
M92.1 Juvenile osteochondrosis of radius and ulna	0.000	0.996	0.004
M92.9 Juvenile osteochondrosis, unspecified	0.000	0.996	0.004
M92.8 Other specified juvenile osteochondrosis	0.000	0.996	0.004
M92.4 Juvenile osteochondrosis of patella	0.000	0.996	0.004
M92.3 Other juvenile osteochondrosis of upper limb	0.000	0.996	0.004
M92.2 Juvenile osteochondrosis of hand	0.000	0.996	0.004
M92.0 Juvenile osteochondrosis of humerus	0.000	0.996	0.004
M93.26 Osteochondritis dissecans knee	0.000	0.996	0.004
M93.86 Other specified osteochondropathies, lower leg	0.000	0.996	0.004
M94.86 Other specified disorders of cartilage (Lower leg)	0.000	0.996	0.004
M47.80 Other spondylosis (Multiple sites in spine)	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
M94.96 Disorder of cartilage, unspecified (Lower leg)	0.000	0.996	0.004
T45.9 Primarily systemic and haematological agent, unspecified	0.004	0.996	0.000
T45.8 Other primarily systemic and haematological agents	0.004	0.996	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
T45.6 Fibrinolysis-affecting drugs	0.004	0.996	0.000
T45.4 Iron and its compounds	0.004	0.996	0.000
T45.3 Enzymes, not elsewhere classified	0.004	0.996	0.000
M94.89 Other specified disorders of cartilage (Site unspecified)	0.000	0.996	0.004
M94.87 Other specified disorders of cartilage (Ankle and foot)	0.000	0.996	0.004
M94.85 Other specified disorders of cartilage (Pelvic region and thigh)	0.000	0.996	0.004
M94.84 Other specified disorders of cartilage (Hand)	0.000	0.996	0.004
M94.83 Other specified disorders of cartilage (Forearm)	0.000	0.996	0.004
M94.82 Other specified disorders of cartilage (Upper arm)	0.000	0.996	0.004
M94.81 Other specified disorders of cartilage (Shoulder region)	0.000	0.996	0.004
M94.80 Other specified disorders of cartilage (Multiple sites)	0.000	0.996	0.004
M91.2 Coxa plana	0.000	0.996	0.003
S89.7 Multiple injuries of lower leg	0.003	0.996	0.000
S89.1 Other specified injuries of lower leg	0.003	0.996	0.000
S89.0 Multiple injuries of lower leg	0.003	0.996	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.003	0.996	0.000
L40 Psoriasis	0.004	0.996	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.004	0.996	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.996	0.004
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.996	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.996	0.000
S86.00 Unspecified injury of Achilles tendon	0.003	0.996	0.000
S89.8 Other specified injuries of lower leg	0.003	0.996	0.000
J95.8 Other postprocedural respiratory disorders	0.003	0.997	0.000
M91.9 Juvenile osteochondrosis of hip and pelvis, unspecified	0.000	0.997	0.003
M91.8 Other juvenile osteochondrosis of hip and pelvis	0.000	0.997	0.003
M91.3 Pseudocoxalgia	0.000	0.997	0.003
M91.1 Juvenile osteochondrosis of head of femur [Legg-Calve-Perthes]	0.000	0.997	0.003
M91.0 Juvenile osteochondrosis of pelvis	0.000	0.997	0.003
M94.99 Disorder of cartilage, unspecified (Site unspecified)	0.000	0.997	0.003
M94.98 Disorder of cartilage, unspecified (Other)	0.000	0.997	0.003
M94.97 Disorder of cartilage, unspecified (Ankle and foot)	0.000	0.997	0.003
M94.95 Disorder of cartilage, unspecified (Pelvic region and thigh)	0.000	0.997	0.003
M94.94 Disorder of cartilage, unspecified (Hand)	0.000	0.997	0.003
M94.93 Disorder of cartilage, unspecified (Forearm)	0.000	0.997	0.003
M94.92 Disorder of cartilage, unspecified (Upper arm)	0.000	0.997	0.003
M94.91 Disorder of cartilage, unspecified (Shoulder region)	0.000	0.997	0.003
M94.90 Disorder of cartilage, unspecified (Multiple sites)	0.000	0.997	0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.003	0.997	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.003	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
T44.0 Anticholinesterase agents	0.003	0.997	0.000
M94.26 Chondromalacia (Lower leg)	0.000	0.997	0.003
G51.0 Bell's palsy	0.003	0.997	0.000
L40.1 Generalised pustular psoriasis	0.003	0.997	0.000
M94.29 Chondromalacia (Site unspecified)	0.000	0.997	0.003
M94.28 Chondromalacia (Other)	0.000	0.997	0.003
M94.27 Chondromalacia (Ankle and foot)	0.000	0.997	0.003
M94.25 Chondromalacia (Pelvic region and thigh)	0.000	0.997	0.003
M94.24 Chondromalacia (Hand)	0.000	0.997	0.003
M94.23 Chondromalacia (Forearm)	0.000	0.997	0.003
M94.22 Chondromalacia (Upper arm)	0.000	0.997	0.003
M94.21 Chondromalacia (Shoulder region)	0.000	0.997	0.003
M94.20 Chondromalacia (Multiple sites)	0.000	0.997	0.003
M94.09 Chondrocostal junction syndrome [Tietze]-Site unspec	0.000	0.997	0.003
M94.08 Chondrocostal junction syndrome [Tietze]-Other	0.000	0.997	0.003
M94.07 Chondrocostal junction syndrome [Tietze]-Ankle/foot	0.000	0.997	0.003
M94.06 Chondrocostal junction syndrome [Tietze]-Lower leg	0.000	0.997	0.003
M94.05 Chondrocostal junction syndrome [Tietze]-Pelvic/thigh	0.000	0.997	0.003
M94.04 Chondrocostal junction syndrome [Tietze]-Hand	0.000	0.997	0.003
M94.03 Chondrocostal junction syndrome [Tietze]-Forearm	0.000	0.997	0.003
M94.02 Chondrocostal junction syndrome [Tietze]-Upper arm	0.000	0.997	0.003
M94.01 Chondrocostal junction syndrome [Tietze]-Shldr region	0.000	0.997	0.003
M94.00 Chondrocostal junction syndrome [Tietze]-Mult sites	0.000	0.997	0.003
M94.19 Relapsing polychondritis (Site unspecified)	0.000	0.997	0.003
M94.18 Relapsing polychondritis (Other)	0.000	0.997	0.003
M94.17 Relapsing polychondritis (Ankle and foot)	0.000	0.997	0.003
M94.16 Relapsing polychondritis (Lower leg)	0.000	0.997	0.003
M94.15 Relapsing polychondritis (Pelvic region and thigh)	0.000	0.997	0.003
M94.14 Relapsing polychondritis (Hand)	0.000	0.997	0.003
M94.13 Relapsing polychondritis (Forearm)	0.000	0.997	0.003
M94.12 Relapsing polychondritis (Upper arm)	0.000	0.997	0.003
M94.11 Relapsing polychondritis (Shoulder region)	0.000	0.997	0.003
M94.10 Relapsing polychondritis (Multiple sites)	0.000	0.997	0.003
M94.39 Chondrolysis (Site unspecified)	0.000	0.997	0.003
M94.38 Chondrolysis (Other)	0.000	0.997	0.003
M94.37 Chondrolysis (Ankle and foot)	0.000	0.997	0.003
M94.36 Chondrolysis (Lower leg)	0.000	0.997	0.003
M94.35 Chondrolysis (Pelvic region and thigh)	0.000	0.997	0.003
M94.34 Chondrolysis (Hand)	0.000	0.997	0.003
M94.33 Chondrolysis (Forearm)	0.000	0.997	0.003
M94.32 Chondrolysis (Upper arm)	0.000	0.997	0.003
M94.31 Chondrolysis (Shoulder region)	0.000	0.997	0.003
M94.30 Chondrolysis (Multiple sites)	0.000	0.997	0.003
C18.4 Transverse colon	0.000	0.997	0.003
A41 Other septicaemia	0.003	0.997	0.000
T36 Poisoning by systemic antibiotics	0.003	0.997	0.000
M92.10 Juvenile osteochondrosis of radius and ulna, unspecified arm	0.000	0.997	0.003
M92.51 Juvenile osteochondrosis of tibia and fibula, right leg	0.000	0.997	0.003
M92.50 Juvenile osteochondrosis of tibia and fibula, unspecified leg	0.000	0.997	0.003
M91.20 Coxa plana-Mult sites	0.000	0.997	0.003
G31.9 Degenerative disease of nervous system, unspecified	0.003	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
G82.2 Paraplegia, unspecified	0.000	0.997	0.003
I08.0 Disorders of both mitral and aortic valves	0.000	0.997	0.003
N80.9 Endometriosis, unspecified	0.000	0.997	0.003
C44.4 Skin of scalp and neck	0.000	0.997	0.003
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
A41.9 Septicaemia, unspecified	0.003	0.997	0.000
L40.8 Other psoriasis	0.003	0.997	0.000
L40.5 Arthropathic psoriasis	0.003	0.997	0.000
T40.2 Other opioids	0.003	0.997	0.000
K06.8 Other specified disorders of gingiva and edentulous alveolar ridge	0.003	0.997	0.000
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.003	0.997	0.000
M91.29 Coxa plana-Site unspec	0.000	0.997	0.003
M91.28 Coxa plana-Other	0.000	0.997	0.003
M91.27 Coxa plana-Ankle/Foot	0.000	0.997	0.003
M91.26 Coxa plana-Lower Leg	0.000	0.997	0.003
M91.25 Coxa plana-Pelvic/Thigh	0.000	0.997	0.003
M91.24 Coxa plana-Hand	0.000	0.997	0.003
M91.23 Coxa plana-Forearm	0.000	0.997	0.003
M91.22 Coxa plana-Upper arm	0.000	0.997	0.003
M91.21 Coxa plana-Shldr region	0.000	0.997	0.003
S81.0 Open wound of knee	0.003	0.997	0.000
S89.9 Unspecified injury of lower leg	0.003	0.997	0.000
L40.4 Guttate psoriasis	0.003	0.997	0.000
L40.3 Pustulosis palmaris et plantaris	0.003	0.997	0.000
L40.2 Acrodermatitis continua	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations